|
COMMD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.592400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.828600E-01 |
| Normal-vs-Stage2 |
9.721800E-01 |
| Normal-vs-Stage3 |
2.144100E-02 |
| Normal-vs-Stage4 |
7.323000E-03 |
| Stage1-vs-Stage2 |
5.104200E-01 |
| Stage1-vs-Stage3 |
2.584100E-04 |
| Stage1-vs-Stage4 |
1.756520E-04 |
| Stage2-vs-Stage3 |
1.134190E-01 |
| Stage2-vs-Stage4 |
8.079700E-02 |
| Stage3-vs-Stage4 |
7.446800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.861600E-01 |
| Normal-vs-AfricanAmerican |
2.910000E-01 |
| Normal-vs-Asian |
6.204800E-01 |
| Caucasian-vs-AfricanAmerican |
4.655000E-01 |
| Caucasian-vs-Asian |
5.421800E-01 |
| AfricanAmerican-vs-Asian |
2.776200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.122400E-01 |
| Normal-vs-Female |
7.704200E-01 |
| Male-vs-Female |
9.400000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.334800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.852200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.712000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.806800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.398400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.587600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.061800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.347600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.164200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.801000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.781300E-03 |
| Normal-vs-Grade 2 |
1.172170E-01 |
| Normal-vs-Grade 3 |
5.758100E-02 |
| Normal-vs-Grade 4 |
1.71538999998999E-05 |
| Grade 1-vs-Grade 2 |
1.599390E-01 |
| Grade 1-vs-Grade 3 |
1.424340E-03 |
| Grade 1-vs-Grade 4 |
2.06139999999744E-05 |
| Grade 2-vs-Grade 3 |
1.246850E-04 |
| Grade 2-vs-Grade 4 |
4.20569999937115E-08 |
| Grade 3-vs-Grade 4 |
9.427600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.303630E-02 |
| Normal-vs-ccB subtype |
3.503900E-02 |
| ccA subtype-vs-ccB subtype |
9.83209999971812E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.748400E-01 |
| Normal-vs-N1 |
2.520400E-01 |
| N0-vs-N1 |
2.623600E-01 |
|
|
